Photo by impulsq from unsplash
Insulin degludec/aspart (IDegAsp) and insulin glargine U300 (IGlarU300) have recently emerged as popular new‐generation insulin analogues. The aim of this real‐life study was to investigate the patient profiles in which… Click to show full abstract
Insulin degludec/aspart (IDegAsp) and insulin glargine U300 (IGlarU300) have recently emerged as popular new‐generation insulin analogues. The aim of this real‐life study was to investigate the patient profiles in which IGlarU300 and IDegAsp were preferred and the insulin combinations after which each of them were mostly used and also to analyse the effect of these two insulin analogues on blood glucose regulation and hypoglycaemia.
Keywords:
insulin;
degludec aspart;
insulin glargine;
glargine u300;
insulin degludec
Journal Title: International Journal of Clinical Practice
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Clinical Practice
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!